Summarized by Masters of Longevity from Longevity Technology.
Fauna Bio and Eli Lilly designated a second obesity target from a different tissue.

Key Takeaways
- Collaboration has produced a second tissue-specific obesity target.
- Designation has triggered additional milestone payments under the collaboration.
- Target validation is ongoing and has not established causal efficacy.



